By
WilD on
September 10, 2012
What would you say if someone offered you a safe pill that could lower your blood sugar, help you lose weight, preserve beta cell function, and keep Alzheimer’s at bay?
Actually, that’s the wrong question. The question isn’t what you would say, but what would you pay?
That’s likely the question that was on the boardroom table at bio-tech firm Metabolic Solutions Development Company (MSDC), when they bet the $55-million farm on their pair of…
Read more »
A week ago, the media was all abuzz about a new study published in the New England Journal of Medicine showing that the oral drug Actos can prevent diabetes. At first we at the ‘Mine didn’t pay much attention, because of course we’re more concerned with what happens to people who already have diabetes. But the buzz didn’t stop. Forbes blogger Matthew Herper wrote a great piece about why side effects make this a bad…
Read more »
By
AmyT on
November 17, 2009
Al Mann, CEO of MannKind Corp., is something of a legend in his own time. He not only founded MiniMed, acquired by Medtronic, but also four other successful medical companies. He’s a billionaire, with his own Biomedical Engineering Institute at the University of Southern California (USC), so we can assume that he’s not just championing the new inhalable insulin product Technosphere (brand name Afresa) as some kind of pipe dream or get-rich-quick scheme.
The guy…
Read more »
By
AmyT on
August 26, 2008
Now this is interesting. Yesterday I received an update from the folks at Manhattan Research on the “Top Pharma Product Site 2008 list” from their latest ePharma Physician® study. To be clear, this study looks at the top product sites visited by doctors, not patients or consumers:
Top 10 Product Sites Visited by Physicians in 2008
Ranked by Number of U.S. Primary Care Physician Visitors
1. Januvia
2. Actos
3. Chantix
4. Gardasil
5. Actonel
6.…
Read more »
